投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
11.2 %
年文章数
1550
作者需知
暂无数据
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Published by Adis International Limited (now part of Wolters Kluwer Health).
ISSN: 1170-7690.
PharmacoEconomics is the benchmark journal for peer reviewed authoritative and practical articles on the application of pharmacoeconomics, outcomes research and quality of life assessment to optimum drug therapy and health outcomes. An invaluable source of pharmacoeconomic research and methodology, PharmacoEconomics provides you with clear communications of complex pharmacoeconomic issues related to patient care and drug utilisation, providing the basis for informed clinical prescribing decisions and allocation of healthcare resources.
PharmacoEconomics is the benchmark journal for peer reviewed authoritative and practical articles on the application of pharmacoeconomics, outcomes research and quality of life assessment to optimum drug therapy and health outcomes. An invaluable source of pharmacoeconomic research and methodology, PharmacoEconomics provides you with clear communications of complex pharmacoeconomic issues related to patient care and drug utilisation, providing the basis for informed clinical prescribing decisions and allocation of healthcare resources.
